Recurrent giant cell fibroblastoma: Malignancy predisposition in Kabuki syndrome revisited

American Journal of Medical Genetics, Part A

Volumn 170, Issue 5, 2016, Pages 1333-1338

  Karagianni, Paraskevi ^a   Lambropoulos, Vassilios ^a   Stergidou, Dorothea ^a   Fryssira, Helena ^b   Chatziioannidis, Ilias ^a   Spyridakis, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Children; Giant cell fibroblastoma; Juvenile fibroblastoma; Kabuki syndrome; KMT2D; Malignancy; MLL2; Soft tissue neoplasm

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CD99 ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN S 100; VIMENTIN; DNA BINDING PROTEIN; HISTONE DEMETHYLASE; MLL2 PROTEIN, HUMAN; NUCLEAR PROTEIN; TUMOR PROTEIN; UTX PROTEIN, HUMAN;

ARTICLE; CANCER SURGERY; CANCER SUSCEPTIBILITY; CASE REPORT; CHILD; CHILDHOOD CANCER; CHROMOSOME 12; CONGENITAL HEART DISEASE; DIFFERENTIAL DIAGNOSIS; FACE DYSMORPHIA; FEMALE; FINGER MALFORMATION; FRAMESHIFT MUTATION; GENE; GENE MUTATION; GENETIC ANALYSIS; GIANT CELL FIBROBLASTOMA; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KABUKI MAKEUP SYNDROME; KIDNEY MALFORMATION; KMT2D GENE; LYMPHANGIOMA; MENTAL DEFICIENCY; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT INFECTION; SARCOMA; SCHOOL CHILD; SOFT TISSUE TUMOR; SPINDLE CELL HEMANGIOMA; TUMOR RECURRENCE; ABNORMALITIES; COMPLICATION; DERMATOFIBROSARCOMA PROTUBERANS; FACE; GENETICS; GENOTYPE; HEMATOLOGIC DISEASE; INTELLECTUAL IMPAIRMENT; MULTIPLE MALFORMATION SYNDROME; MUTATION; PATHOPHYSIOLOGY; VESTIBULAR DISORDER;

ABNORMALITIES, MULTIPLE; CHILD; DERMATOFIBROSARCOMA; DNA-BINDING PROTEINS; FACE; FEMALE; GENOTYPE; HEMATOLOGIC DISEASES; HISTONE DEMETHYLASES; HUMANS; INTELLECTUAL DISABILITY; MUTATION; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; VESTIBULAR DISEASES;

EID: 84958720848     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.37584     Document Type: Article

References (49)

1. Aliağaoğlu C, Bakan V, Atasoy M, Sahin O, Toker S, Albayrak M. 2006. A very large, rapidly developing, congenital giant cell fibroblastoma in a 5-month old infant. J Dermatol 33:182-186.
2. Berdasco M, Esteller M. 2013. Genetic syndromes caused by mutations in epigenetic genes. Hum Genet. 132:359-383.
3. Casanova M, Selicorni A, Ferrari A. 2011. Cancer predisposition in children with Kabuki syndrome. Am J Med Genet Part A 155A:1504.
4. Courcet JB, Faivre L, Michot C, Burguet A, Perez-Martin S, Alix E, Amiel J, Baumann C, Cordier MP, Cormier-Daire V, Delrue MA, Gilbert-Dussardier B, Goldenberg A, Jacquemont ML, Jaquette A, Kayirangwa H, Lacombe D, Le Merrer M, Toutain A, Odent S, Moncla A, Pelet A, Philip N, Pinson L, Poisson S, Kim-Han le QS, Roume J, Sanchez E, Willems M, Till M, Vincent-Delorme C, Mousson C, Vinault S, Binquet C, Huet F, Sarda P, Salomon R, Lyonnet S, Sanlaville D, Geneviève D. 2013. Clinical and molecular spectrum of renal malformations in Kabuki syndrome. J Pediatr 163:742-746.
5. Cuesta L, Betlloch I, Toledo F, Latorre N, Monteagudo AF. 2011. Kabuki syndrome: A new case associated with Becker nevus. Dermatol Online J 17:1.
6. Dal Cin P, Sciot R, de Wever I, Brock P, Casteels-Van Daele M, Van Damme B, Van Den Berghe H. 1996. Cytogenetic and immunohistochemical evidence that giant cell fibroblastoma is related to dermatofibrosarcoma protuberans. Genes Chromosomes Cancer 15:73-75.
7. Díaz-Flores L, Gutiérrez R, García MP, Sáez FJ, Díaz-Flores L Jr, Valladares F, Madrid JF. 2014. CD34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function, and role in pathology. Histol Histopathol 29:831-870.
8. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B. 2001. Congenital heart defects in Kabuki syndrome. Am J Med Genet 100:269-274.
9. Dubuc AM, Remke M, Korshunov A, Northcott PA, Zhan SH, Mendez-Lago M, Kool M, Jones DT, Unterberger A, Morrissy AS, Shih D, Peacock J, Ramaswamy V, Rolider A, Wang X, Witt H, Hielscher T, Hawkins C, Vibhakar R, Croul S, Rutka JT, Weiss WA, Jones SJ, Eberhart CG, Marra MA, Pfister SM, Taylor MD. 2013. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol 125:373-384.
10. Dymock RB, Allen PW, Stirling JW, Gilbert EF, Thornbery JM. 1987. Giant cell fibroblastoma. A distinctive, recurrent tumor of childhood. Am J Surg Pathol 11:263-271.
11. Ford DJ, Dingwall AK. 2015. The cancer COMPASS: Navigating the functions of MLL complexes in cancer. Cancer Genet 208:178-191.
12. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S, editors. 2013. World Health Organization classification of tumors. International classification of diseases for oncology, third edition, first revision. Geneva: World Health Organization. p 72.
13. Goldblum JR. 1996. Giant cell fibroblastoma: A report of three cases with histologic and immunohistochemical evidence of a relationship to dermatofibrosarcoma protuberans. Arch Pathol Lab Med 120:1052-1055.
14. Guo C, Chen LH, Huang Y, Chang CC, Wang P, Pirozzi CJ, Qin X, Bao X, Greer PK, McLendon RE, Yan H, Keir ST, Bigner DD, He Y. 2013. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation. Oncotarget 4:2144-2153.
15. Hamahata A, Kamei W, Ishikawa M, Konoeda H, Yamaki T, Sakurai H. 2013. Multiple pilomatricomas in Kabuki syndrome. Pediatr Dermatol 30:253-255.
16. Hannibal MC, Buckingham KJ, Ng SB, Ming JE, Beck AE, McMillin MJ, Gildersleeve HI, Bigham AW, Tabor HK, Mefford HC, Cook J, Yoshiura K, Matsumoto T, Matsumoto N, Miyake N, Tonoki H, Naritomi K, Kaname T, Nagai T, Ohashi H, Kurosawa K, Hou JW, Ohta T, Liang D, Sudo A, Morris CA, Banka S, Black GC, Clayton-Smith J, Nickerson DA, Zackai EH, Shaikh TH, Donnai D, Niikawa N, Shendure J, Bamshad MJ. 2011. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am J Med Genet Part A 155A:1511-1516.
17. Hoffman JD, Ciprero KL, Sullivan KE, Kaplan PB, McDonald-McGinn DM, Zackai EH, Ming JE. 2005. Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet Part A 135:278-281.
18. Hoos A, Stojadinovic A, Mastorides S, Urist MJ, Polsky D, Di Como CJ, Brennan MF, Cordon-Cardo C. 2001. High Ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas. Cancer 92:869-874.
19. Huether R, Dong L, Chen X, Wu G, Parker M, Wei L, Ma J, Edmonson MN, Hedlund EK, Rusch MC, Shurtleff SA, Mulder HL, Boggs K, Vadordaria B, Cheng J, Yergeau D, Song G, Becksfort J, Lemmon G, Weber C, Cai Z, Dang J, Walsh M, Gedman AL, Faber Z, Easton J, Gruber T, Kriwacki RW, Partridge JF, Ding L, Wilson RK, Mardis ER, Mullighan CG, Gilbertson RJ, Baker SJ, Zambetti G, Ellison DW, Zhang J, Downing JR. 2014. The landscape of somatic mutations in epigenetic regulators across 1, 000 paediatric cancer genomes. Nat Commun 5:3630.
20. Ijichi O, Kawakami K, Matsuda Y, Ikarimoto N, Miyata K, Takamatsu H, Tokunaga M. 1996. A case of Kabuki make-up syndrome with EBV+Burkitt's lymphoma. Acta Paediatr Jpn 38:66-68.
21. Ito N, Ihara K, Tsutsumi Y, Miyake N, Matsumoto N, Hara T. 2013. Hypothalamic pituitary complications in Kabuki syndrome. Pituitary 16:133-138.
22. Jha P, Moosavi C, Fanburg-Smith JC. 2007. Giant cell fibroblastoma: An update and addition of 86 new cases from the armed forces institute of pathology, in honor of Dr. Franz M Enzinger. Ann Diagn Pathol 11:81-88.
23. Kawame H, Hannibal MC, Hudgins L, Pagon RA. 1999. Phenotypic spectrum and management issues in Kabuki syndrome. J Pediatr 134:480-485.
24. Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I. 1981. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr 99:570-573.
25. Lederer D, Grisart B, Digilio MC, Benoit V, Crespin M, Ghariani SC, Maystadt I, Dallapiccola B, Verellen-Dumoulin C. 2012. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 90:119-124.
26. Li J, Thompson TD, Miller JW, Pollack LA, Stewart SL. 2008. Cancer incidence among children and adolescents in the United States, 2001-2003. Pediatrics 121:e1470-e1477.
27. Lindqvist CM, Nordlund J, Ekman D, Johansson A, Moghadam BT, Raine A, Övernäs E, Dahlberg J, Wahlberg P, Henriksson N, Abrahamsson J, Frost BM, Grandér D, Heyman M, Larsson R, Palle J, Söderhäll S, Forestier E, Lönnerholm G, Syvänen AC, Berglund EC. 2015. The mutational landscape in pediatric acute lymphoblastic leukemia deciphered by whole genome sequencing. Hum Mutat 36:118-128.
28. Makrythanasis P, van Bon BW, Steehouwer M, Rodríguez-Santiago B, Simpson M, Dias P, Anderlid BM, Arts P, Bhat M, Augello B, Biamino E, Bongers EM, Del Campo M, Cordeiro I, Cueto-González AM, Cuscó I, Deshpande C, Frysira E, Izatt L, Flores R, Galán E, Gener B, Gilissen C, Granneman SM, Hoyer J, Yntema HG, Kets CM, Koolen DA, Marcelis Cl, Medeira A, Micale L, Mohammed S, de Munnik SA, Nordgren A, Psoni S, Reardon W, Revencu N, Roscioli T, Ruiterkamp-Versteeg M, Santos HG, Schoumans J, Schuurs-Hoeijmakers JH, Silengo MC, Toledo L, Vendrell T, van der Burgt I, van Lier B, Zweier C, Reymond A, Trembath RC, Perez-Jurado L, Dupont J, de Vries BB, Brunner HG, Veltman JA, Merla G, Antonarakis SE, Hoischen A. 2013. MLL2 mutation detection in 86 patients with Kabuki syndrome: A genotype-phenotype study. Clin Genet 84:539-545.
29. Matsune K, Shimizu T, Tohma T, Asada Y, Ohashi H, Maeda T. 2001. Craniofacial and dental characteristics of Kabuki syndrome. Am J Med Genet 98:185-190.
30. McGaughran JM, Donnai D, Clayton-Smith J. 2000. Biliary atresia in Kabuki syndrome. Am J Med Genet 91:157-158.
31. Merks JH, Caron HN, Hennekam RC. 2005. High incidence of malformation syndromes in a series of 1, 073 children with cancer. Am J Med Genet Part A 134A:132-143.
32. Miyake N, Koshimizu E, Okamoto N, Mizuno S, Ogata T, Nagai T, Kosho T, Ohashi H, Kato M, Sasaki G, Mabe H, Watanabe Y, Yoshino M, Matsuishi T, Takanashi J, Shotelersuk V, Tekin M, Ochi N, Kubota M, Ito N, Ihara K, Hara T, Tonoki H, Ohta T, Saito K, Matsuo M, Urano M, Enokizono T, Sato A, Tanaka H, Ogawa A, Fujita T, Hiraki Y, Kitanaka S, Matsubara Y, Makita T, Taguri M, Nakashima M, Tsurusaki Y, Saitsu H, Yoshiura K, Matsumoto N, Niikawa N. 2013. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet Part A 161A:2234-2243.
33. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, Beck AE, Tabor HK, Cooper GM, Mefford HC, Lee C, Turner EH, Smith JD, Rieder MJ, Yoshiura K, Matsumoto N, Ohta T, Niikawa N, Nickerson DA, Bamshad MJ, Shendure J. 2010. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42:790-793.
34. Nguyen CM, Burch JM, Fitzpatrick JE, Peterson SL, Weston WL. 2002. Giant cell fibroblastoma in a child misdiagnosed as a dermatofibroma. Pediatr Dermatol 19:28-32.
35. Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. 1981. Kabuki make-up syndrome: A syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr 99:565-569.
36. Ortega-Molina A, Boss IW, Canela A, Pan H, Jiang Y, Zhao C, Jiang M, Hu D, Agirre X, Niesvizky I, Lee JE, Chen HT, Ennishi D, Scott DW, Mottok A, Hother C, Liu S, Cao XJ, Tam W, Shaknovich R, Garcia BA, Gascoyne RD, Ge K, Shilatifard A, Elemento O, Nussenzweig A, Melnick AM, Wendel HG. 2015. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med 21:1199-1208.
37. Paulussen AD, Stegmann AP, Blok MJ, Tserpelis D, Posma-Velter C, Detisch Y, Smeets EE, Wagemans A, Schrander JJ, van den Boogaard MJ, van der Smagt J, van Haeringen A, Stolte-Dijkstra I, Kerstjens-Frederikse WS, Mancini GM, Wessels MW, Hennekam RC, Vreeburg M, Geraedts J, de Ravel T, Fryns JP, Smeets HJ, Devriendt K, Schrander-Stumpel CT. 2011. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat 32:E2018-E2025.
38. Roma D, Palma P, Capolino R, Figà-Talamanca L, Diomedi-Camassei F, Lepri FR, Digilio MC, Marras CE, Messina R, Carai A, Randi F, Mastronuzzi A. 2015. Spinal ependymoma in a patient with Kabuki syndrome: A case report. BMC Med Genet 16:80.
39. Scherer S, Theile U, Beyer V, Ferrari R, Kreck C, Rister M. 2003. Patient with Kabuki syndrome and acute leukemia. Am J Med Genet Part A 122A:76-79.
40. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. 2007. Genome regulation by polycomb and trithorax proteins. Cell 128:735-745.
41. Segura S, Salgado R, Toll A, Martín-Ezquerra G, Yébenes M, Sáez A, Solé F, Barranco C, Umbert P, Espinet B, Pujol RM. 2011. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays. Hum Pathol 42:176-184.
42. Shahdadpuri R, O'Meara A, O'Sullivan M, Reardon W. 2008. Low-grade fibromyxoid sarcoma: Yet another malignancy associated with Kabuki syndrome. Clin Dysmorphol 17:199-202.
43. Shmookler BM, Enzinger FM, Weiss SW. 1989. Giant cell fibroblastoma. A juvenile form of dermatofibrosarcoma protuberans. Cancer 64:2154-2161.
44. Simon MP, Pedeutour F, Sirvent N, Grosgeorge J, Minoletti F, Coindre JM, Terrier-Lacombe MJ, Mandahl N, Craver RD, Blin N, Sozzi G, Turc-Carel C, O'Brien KP, Kedra D, Fransson I, Guilbaud C, Dumanski JP. 1997. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat Genet 15:95-98.
45. Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM. 2003. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: Clinicopathologic comparative analysis of 28 cases with molecular data-a study from the French Federation of Cancer Centers Sarcoma Group. Am J Surg Pathol 27:27-39.
46. Tumino M, Licciardello M, Sorge G, Cutrupi MC, Di Benedetto F, Amoroso L, Catania R, Pennisi M, D'Amico S, Di Cataldo A. 2010. Kabuki syndrome and cancer in two patients. Am J Med Genet Part A 152A:1536-1539.
47. Wang J, Coltrera MD, Gown AM. 1994. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: An immunohistochemical and in situ hybridization study. Cancer Res 54:560-564.
48. White SM, Thompson EM, Kidd A, Savarirayan R, Turner A, Amor D, Delatycki MB, Fahey M, Baxendale A, White S, Haan E, Gibson K, Halliday JL, Bankier A. 2004. Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. Am J Med Genet Part A 127A:118-127.
49. Zhang J, Dominguez-Sola D, Hussein S, Lee JE, Holmes AB, Bansal M, Vlasevska S, Mo T, Tang H, Basso K, Ge K, Dalla-Favera R, Pasqualucci L. 2015. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med 21:1190-1198.